AI assistant
AMGEN INC — Director's Dealing 2020
Aug 24, 2020
29819_dirs_2020-08-24_3651a4a4-96e9-4c1f-8bf9-ba8ddd83163b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2020-08-21
Reporting Person: AMGEN INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-21 | American Depositary Shares | A | 64176 | $230.1797 | Acquired | 18405593 | Direct |
| 2020-08-24 | American Depositary Shares | A | 59390 | $239.0959 | Acquired | 18464983 | Direct |
Footnotes
F1: This transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
F2: The price reported is an average price. These American Depositary Shares ("ADSs") were purchased at prices ranging from $237.33 to $243.11 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F3: The price reported is an average price. These ADSs were purchased at prices ranging from $235.15 to $242.535 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F4: As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 240,044,779 Ordinary Shares.